Zevra Therapeutics (ZVRA) Insider Trading & Ownership $9.37 -0.01 (-0.11%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Zevra Therapeutics (NASDAQ:ZVRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.40%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$226.25KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$674.18K Get ZVRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ZVRA Insider Buying and Selling by Quarter Zevra Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/28/2025Corey Michael WattonDirectorBuy300$7.84$2,352.00 3/19/2025John B BodeDirectorBuy10,000$7.96$79,600.00 2/13/2025Joshua SchaferEVPSell10,500$7.86$82,530.00 2/13/2025Neil F McfarlaneCEOSell61,273$7.86$481,605.78 2/13/2025R. Laduane CliftonCFOSell11,000$7.86$86,460.00 2/13/2025Timothy J SangiovanniSVPSell3,000$7.86$23,580.00 10/11/2024Corey Michael WattonDirectorBuy500$7.92$3,960.00 7/17/2024R. Laduane CliftonCFOBuy2,000$6.77$13,540.00 7/16/2024Thomas AndersonDirectorBuy10,000$6.81$68,100.00 7/12/2024John B BodeDirectorBuy10,000$5.87$58,700.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) ZVRA Insider Trading Activity - Frequently Asked Questions Who is on Zevra Therapeutics's Insider Roster? The list of insiders at Zevra Therapeutics includes Corey Michael Watton, John B Bode, Joshua Schafer, Matthew R Plooster, Neil F Mcfarlane, R. Laduane Clifton, Richard W Pascoe, Tamara A Seymour, Thomas Anderson, and Timothy J Sangiovanni. Learn more on insiders at ZVRA. What percentage of Zevra Therapeutics stock is owned by insiders? 2.40% of Zevra Therapeutics stock is owned by insiders. Learn more on ZVRA's insider holdings. Which Zevra Therapeutics insiders have been buying company stock? The following insiders have purchased ZVRA shares in the last 24 months: Corey Michael Watton ($7,948.25), John B Bode ($189,600.00), Joshua Schafer ($2,565.00), R. Laduane Clifton ($18,500.00), and Thomas Anderson ($68,100.00). How much insider buying is happening at Zevra Therapeutics? Insiders have purchased a total of 44,575 ZVRA shares in the last 24 months for a total of $286,713.25 bought. Which Zevra Therapeutics insiders have been selling company stock? The following insiders have sold ZVRA shares in the last 24 months: Joshua Schafer ($82,530.00), Neil F Mcfarlane ($481,605.78), R. Laduane Clifton ($86,460.00), and Timothy J Sangiovanni ($23,580.00). How much insider selling is happening at Zevra Therapeutics? Insiders have sold a total of 85,773 Zevra Therapeutics shares in the last 24 months for a total of $674,175.78 sold. Zevra Therapeutics Key ExecutivesMr. Neil F. McFarlane (Age 51)President, CEO & Director Compensation: $503.77k1 recent tradesMs. Christal M. M. Mickle M.A. (Age 45)Co-Founder & Chief Development Officer Compensation: $622.36kMr. R. LaDuane Clifton CPA (Age 52)CFO, Secretary & Treasurer Compensation: $658.43k1 recent tradesMr. Joshua M. Schafer M.B.A. (Age 52)Chief Commercial Officer & Executive VP of Business Development Compensation: $766.07kDr. Sven Guenther Ph.D. (Age 52)Chief Scientific Officer Compensation: $497.26kMs. Nichol L. OchsnerVice President of Investor Relations & Corporate CommunicationsMr. Rahsaan W. Thompson J.D. (Age 53)Chief Legal Officer, Secretary & Compliance Officer Ms. Alison PetersChief People OfficerDr. Christopher M. Lauderback Ph.D. (Age 49)Senior Vice President of Manufacturing Dr. Rene A. Braeckman Ph.D.Senior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies Agios Pharmaceuticals Insider Trades IDEAYA Biosciences Insider Trades Twist Bioscience Insider Trades Apogee Therapeutics Insider Trades Immunocore Insider Trades Beam Therapeutics Insider Trades Tarsus Pharmaceuticals Insider Trades Schrödinger Insider Trades Bausch Health Companies Insider Trades Biohaven Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:ZVRA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zevra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZVRA Stock Free ZVRA Stock Alerts